In this session from the SOHO Insider Community Oncology series, Shakira J. Grant, MBBS, MSCR, founder and CEO of CROSS Global Research and Strategy, discusses how artificial intelligence is shaping pathology workflows and clinical treatment decisions in hematology and oncology.
Host Dr. Loretta Nastoupil discusses with Dr. Grant the practical adoption of ambient AI scribe technologies, diagnostic applications in hematopathology, and clinical decision support tools, as well as the importance of maintaining human oversight to ensure patient safety and address challenges around clinical accuracy, coding intensity, and health equity.
Leave feedback about this